The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 09, 2021
Filed:
Oct. 12, 2017
Applicant:
Institute for Research IN Biomedicine, Bellinzona, CH;
Inventors:
Assignee:
INSTITUTE FOR RESEARCH IN BIOMEDICINE, Bellinzona, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/164 (2006.01); A61K 38/43 (2006.01); A61P 35/00 (2006.01); A61K 31/198 (2006.01); A61K 35/17 (2015.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); C07K 14/47 (2006.01); A61P 31/00 (2006.01); A61K 31/00 (2006.01); A61P 31/02 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/43 (2013.01); A61K 31/00 (2013.01); A61K 31/198 (2013.01); A61K 35/17 (2013.01); A61K 38/1709 (2013.01); A61K 38/18 (2013.01); A61K 48/005 (2013.01); A61P 31/00 (2018.01); A61P 31/02 (2018.01); A61P 35/00 (2018.01); C07K 14/4702 (2013.01);
Abstract
The present invention provides novel uses and methods for T cell based immunotherapies. Specifically, the invention relates to novel ligands, targets and nucleic acids and vectors encoding said targets that are useful for modulating T cell responses.